Cellectis S.A. (CLLS) Earnings Dates & History
NASDAQ·Healthcare·Biotechnology
$3.10
+0.32%
Mkt Cap $361.10M
EPS — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 19, 2026 | $13.39M | $12.20M | -8.87% | -$0.20 | -$0.26 | -27.87% |
| Q4 2025 Nov 7, 2025 | $10.27M | $35.17M | +242.39% | -$0.10 | $0.01 | +110.00% |
| Q3 2025 Aug 4, 2025 | $8.22M | $16.94M | +106.00% | -$0.10 | -$0.24 | -140.00% |
| Q2 2025 May 12, 2025 | $12.71M | $10.65M | -16.18% | -$0.19 | -$0.18 | +5.26% |
| Q1 2025 Mar 13, 2025 | $9.17M | $12.72M | +38.68% | $0.06 | -$0.16 | -366.67% |
| Q4 2024 Nov 4, 2024 | $20.42M | $16.20M | -20.65% | -$0.20 | -$0.23 | -15.00% |
| Q3 2024 Aug 6, 2024 | $3.47M | $8.06M | +132.31% | -$0.33 | -$0.28 | +15.15% |
| Q2 2024 Apr 29, 2024 | $3.47M | $4.53M | +30.49% | -$0.33 | -$0.64 | -93.94% |
| Q1 2024 Mar 13, 2024 | $1.75M | $283.00K | -83.81% | -$0.22 | -$0.70 | -218.18% |
| Q4 2023 Nov 6, 2023 | $3.38M | $155.00K | -95.42% | -$0.36 | -$0.31 | +13.89% |
| Q3 2023 Aug 3, 2023 | $4.48M | $178.00K | -96.02% | -$0.38 | -$0.14 | +63.16% |
| Q2 2023 May 4, 2023 | $5.99M | $139.00K | -97.68% | -$0.30 | -$0.58 | -93.33% |
| Q1 2023 Mar 8, 2023 | $18.58M | $16.02M | -13.76% | -$0.75 | -$0.57 | +24.00% |
| Q4 2022 Nov 3, 2022 | $16.88M | $217.00K | -98.71% | -$0.58 | -$0.63 | -8.62% |
| Q3 2022 Aug 4, 2022 | $23.46M | $1.35M | -94.25% | -$0.73 | -$0.42 | +42.47% |
| Q2 2022 May 12, 2022 | $18.60M | $1.70M | -90.88% | -$0.62 | -$0.70 | -12.90% |
| Q1 2022 Mar 3, 2022 | $9.86M | $13.65M | +38.44% | -$1.05 | -$0.55 | +47.62% |
| Q4 2021 Nov 4, 2021 | $11.43M | $8.31M | -27.28% | -$0.82 | -$0.82 | +0.00% |
| Q3 2021 Aug 5, 2021 | $14.62M | $11.18M | -23.53% | -$0.75 | -$0.88 | -17.33% |
| Q2 2021 May 6, 2021 | — | $25.60M | — | -$0.82 | -$0.28 | +65.85% |
| Q1 2021 Mar 4, 2021 | — | $13.65M | — | -$1.01 | -$0.95 | +5.94% |
| Q4 2020 Nov 5, 2020 | $8.03M | $6.18M | -23.04% | -$0.69 | -$0.71 | -2.90% |
| Q3 2020 Aug 5, 2020 | $9.00M | $2.90M | -67.77% | -$0.73 | -$0.76 | -4.11% |
| Q2 2020 May 6, 2020 | $6.38M | $50.13M | +685.25% | -$0.65 | $0.47 | +172.31% |
| Q1 2020 Mar 4, 2020 | — | $4.42M | — | -$0.84 | -$0.88 | -4.76% |
| Q4 2019 Nov 6, 2019 | $11.65M | $8.49M | -27.14% | -$0.89 | -$0.23 | +74.16% |
| Q3 2019 Aug 6, 2019 | $787.20K | $1.15M | +46.34% | -$0.65 | -$0.79 | -21.54% |
| Q2 2019 May 7, 2019 | — | $1.04M | — | -$0.67 | -$0.36 | +46.27% |
| Q1 2019 Mar 11, 2019 | — | $968.00K | — | -$0.24 | -$0.37 | -54.17% |
| Q4 2018 Nov 13, 2018 | $1.01M | $905.00K | -10.29% | -$0.20 | -$0.36 | -80.00% |
| Q3 2018 Aug 1, 2018 | $7.84M | $5.05M | -35.62% | -$0.34 | $0.03 | +108.82% |
| Q2 2018 May 7, 2018 | — | $6.04M | — | -$0.66 | -$0.39 | +40.91% |
| Q1 2018 Mar 12, 2018 | — | $5.72M | — | -$0.64 | -$0.76 | -18.75% |
| Q4 2017 Nov 13, 2017 | $4.54M | $6.12M | +34.88% | -$0.57 | -$0.73 | -28.07% |
| Q3 2017 Aug 2, 2017 | $6.44M | $6.75M | +4.76% | -$0.59 | -$0.39 | +33.90% |
| Q2 2017 May 9, 2017 | — | $6.76M | — | -$0.56 | -$0.56 | +0.00% |
| Q1 2017 Mar 6, 2017 | — | $7.99M | — | -$0.34 | $0.02 | +105.88% |
| Q4 2016 Nov 22, 2016 | $15.58M | $11.32M | -27.35% | -$0.90 | -$0.02 | +97.78% |
| Q3 2016 Sep 8, 2016 | — | $17.60M | — | -$0.44 | $0.26 | +159.09% |
| Q2 2016 May 11, 2016 | — | $7.91M | — | -$0.35 | -$0.51 | -45.71% |
| Q1 2016 Mar 16, 2016 | — | $29.51M | — | -$0.30 | $0.65 | +316.67% |
| Q4 2015 Nov 19, 2015 | $8.55M | $8.55M | +0.00% | -$0.30 | -$0.40 | -33.33% |
| Q3 2015 Sep 9, 2015 | — | $8.22M | — | -$0.36 | -$0.63 | -75.00% |
| Q2 2015 Jun 9, 2015 | — | $9.13M | — | $0.03 | $0.26 | +749.95% |
| Q1 2015 Mar 25, 2015 | — | $10.21M | — | — | $0.16 | — |
| Q4 2014 Dec 31, 2014 | — | $9.79M | — | — | $0.15 | — |
| Q2 2014 Jun 30, 2014 | — | $7.03M | — | — | -$0.13 | — |
| Q1 2014 Mar 31, 2014 | — | $7.08M | — | — | -$0.14 | — |
| Q4 2013 Dec 31, 2013 | — | $5.19M | — | — | -$0.37 | — |
| Q3 2013 Sep 30, 2013 | — | $5.10M | — | — | -$0.36 | — |
| Q2 2013 Jun 30, 2013 | — | $3.37M | — | — | -$0.47 | — |
| Q1 2013 Mar 31, 2013 | — | $3.33M | — | — | -$0.46 | — |
| Q4 2012 Dec 31, 2012 | — | $2.80M | — | — | -$14.67 | — |
| Q3 2012 Sep 30, 2012 | — | $8.70M | — | — | -$0.32 | — |
| Q4 2011 Dec 31, 2011 | — | $20.73M | — | — | -$0.55 | — |